findmyKOL
Clinical trialNCT03643224CompletedInterventional

DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

SponsorMedtronic Cardiac Ablation SolutionsEnrollment376Atrial FibrillationPersistent Atrial Fibrillation
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Andrea Natale, MD

    Director, Electrophysiology, Texas Cardiac Arrhythmia Institute at St. David's Medical Center

    Principal Investigator
  • Atul Verma, MD

    Medical Director, Heart Rhythm Program, Southlake Regional Health Centre

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Southlake Regional Health Center

    Newmarket, Ontario, Canada

  • Montreal Heart Institute

    Montreal, Quebec, Canada

  • Institut Universitaire de Cardiologie Et de Pneumologie de Québec (iucpq)

    Québec, Quebec, Canada

Czechia
  • Institut Klinicke A Experimentalni Mediciny (ikem)

    Prague, Czechia, Czechia

  • Na Homolce

    Prague, Prague, Czechia

  • St Ann'S University Hospital

    Brno, Czechia

France
  • Clinique Du Tonkin

    Villeurbanne, Lyon, France

  • Chru Nancy

    Nancy, France

  • Clinique Saint Pierre

    Perpignan, France

  • Clinique Pasteur

    Toulouse, France

Germany
  • Leipzig Heart Institute Gmbh

    Leipzig, Germany

Italy
  • Centro Cardiologico Monzino

    Milan, Milano, Italy

  • Ospedale Dell'Angelo

    Venezia, Italy

United States
  • Grandview Medical Center

    Birmingham, Alabama, United States

  • University of Alabama

    Birmingham, Alabama, United States

  • Keck School of Medicine

    Los Angeles, California, United States

  • Advent Health, Florida Hospital Orlando

    Orlando, Florida, United States

  • Iowa Heart Center

    West Des Moines, Iowa, United States

  • Kansas City Heart Rhythm Institute

    Overland Park, Kansas, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Jackson Heart Clinic

    Jackson, Mississippi, United States

  • North Mississippi Medical Center

    Tupelo, Mississippi, United States

  • Icahn School of Medicine at Mount Sinai

    New York, New York, United States

  • Montefiore Medical Center

    New York, New York, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • Trident Medical Center

    Charleston, South Carolina, United States

  • Texas Cardiac Arrhythmia Research Foundation

    Austin, Texas, United States

  • Houston Methodist Hospital

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Sept 2018
Primary completion
31 Oct 2024
Completion
31 Oct 2024
Last update posted
23 Oct 2025
Registered enrollment
376
Registry id
NCT03643224

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.